Form 483

Merck Sharp & Dohme LLC Form 483, 2019-04-30

FDA issued a Form 483 to Merck Sharp & Dohme LLC on 2019-04-30 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Merck Sharp & Dohme LLC · West Point, United States · Issued April 30, 2019

Overview

  • 2 public-safe observations are available for this inspection.
  • 1 structured CFR citation is represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

30 Apr 2019
21 CFR 58.130(a)

Conduct: in accordance with protocol

Cited by Anastasia I Offordile, Kelly N Kerr, Anastasia I Onuorah

30 Apr 2019
21 CFR 58.130(a)

Conduct: in accordance with protocol

Cited by Anastasia I Offordile, Kelly N Kerr, Anastasia I Onuorah

Inspected site

MSMerck Sharp & Dohme LLCWest Point, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 58.130(a)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 2 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere